Renaissance Capital logo

Pulmonx Priced, Nasdaq: LUNG

Makes minimally invasive system to treat severe emphysema.

Industry: Health Care

Latest Trade: $39.87 +0.25 (+0.6%)

First Day Return: +106.9%

Return from IPO: +108.5%

Industry: Health Care

We are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Our solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. We estimate our solution currently addresses approximately 500,000 patients in the United States and 700,000 patients in select international markets, which represents a global market opportunity of approximately $12 billion. We have a compelling body of clinical evidence with over 100 scientific articles published regarding the clinical benefits of Zephyr Valves, including in The New England Journal of Medicine, The Lancet and the American Journal of Respiratory and Critical Care Medicine. Multiple randomized controlled clinical trials have demonstrated that patients selected with the Chartis System and successfully treated with Zephyr Valves have shown statistically and clinically significant improvements in lung function, exercise capacity and quality of life compared to medical management alone.
more less
IPO News for Pulmonx
more
IPO Data
IPO File Date 09/04/2020
Offer Price $19.00
Price Range $17.00 - $18.00
Offer Shares (mm) 10.0
Deal Size ($mm) $190
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/30/2020
Offer Price $19.00
Price Range $17.00 - $18.00
Offer Shares (mm) 10.0
Deal Size ($mm) $190
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Redwood City, CA
Founded 1995
Employees 202
Website www.pulmonx.com